&w=3840&q=100)
Tech meets touch: How doctors are adapting to the digital transformation of healthcare
As technology continues to transform healthcare at an unprecedented pace, doctors are learning to walk the tightrope between innovation and intuition. From AI-powered diagnostics to telemedicine platforms and wearable tech, physicians across India are adopting new tools with cautious optimism but insist that the irreplaceable human touch remains at the core of healing.
Dr. Ajay Agarwal, Senior Director of Internal Medicine at Fortis Hospital (Noida) believes that while digital innovation brings undeniable efficiency, it must be grounded in clinical wisdom. 'We must navigate this transformation with a blend of cautious optimism and evolving pragmatism,' he said. Telemedicine for instance, has become a permanent fixture in healthcare practice, especially for chronic disease follow-ups and preliminary triage.
STORY CONTINUES BELOW THIS AD
'It has enhanced accessibility and allowed us to manage patients remotely with greater ease,' Dr. Agarwal added. 'But subtle diagnostic cues like a patient's gait, expressions or behavioural signs—are still best read in person.'
AI, meanwhile, is viewed by Dr. Agarwal as a powerful assistant rather than a replacement. 'It opens doors to deeper clinical reasoning by highlighting imaging patterns and supporting diagnosis, but its integration must be critically evaluated by trained physicians,' he said.
Digital health portals and patient records available online have also improved data sharing across hospitals, bridging long-standing communication gaps. Still, he added, 'The art of understanding the person behind the illness, that is something no tool can replicate.'
Dr. Tushar Tayal, Consultant in Internal Medicine at CK Birla Hospital (Gurugram) echoed this sentiment, saying that technology has permanently altered the landscape of healthcare. 'The COVID-19 pandemic accelerated a shift that was already underway,' he says. Telemedicine has evolved from a peripheral service to a mainstay of patient care, particularly useful for mental health, routine follow-ups and care in underserved regions.
'Doctors have had to develop virtual bedside manners—learning how to maintain empathy and build trust through a screen.'
AI's role in diagnostics is particularly pronounced in radiology, pathology, and dermatology, where pattern recognition can be enhanced by machine learning. 'These tools help reduce errors and allow us to focus more on patient interaction,' Dr. Tayal added.
STORY CONTINUES BELOW THIS AD
Wearables and mobile health apps are another frontier. Devices that monitor heart rate, blood sugar, and sleep patterns now offer real-time data that can inform personalised treatment plans. 'Doctors are collaborating with data scientists to make sense of this information,' he said. Medical education is also adapting, with new training modules focusing on digital ethics, AI tools and critical data analysis.
Still, the integration of tech in healthcare isn't without its challenges. Data privacy, screen fatigue and the risk of over-reliance on algorithms remain key concerns. Yet both doctors agree that rather than replacing physicians, technology is expanding their role. Today's doctors are no longer just healers, they are digital guides, interpreters of complex data and managers of virtual care ecosystems.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
41 minutes ago
- Time of India
Hassan heart attack death cases: India's top drugmakers rally behind Covid vaccines
Leading drugmakers on Thursday rallied in support of Covid vaccines , using various social media platforms, amid a series of deaths in Karnataka's Hassan district due to heart attacks. Dilip Shanghvi, chairman and managing director at Sun Pharmaceuticals said in a post on LinkedIn, 'The deaths of multiple young individuals in one district of Karnataka due to cardiac ailments are unfortunate. While this appears to be specific to the district, linking it to the Covid-19 vaccine without any scientific evidence is "incorrect and misleading". "India's vaccine approval process is rigorous and science-driven, and we must continue to have confidence in it. The vaccine has been administered to millions across the country. If there were a connection, we would have seen similar incidents in many other places — which is not the case. The State health authorities should thoroughly investigate the situation to determine the cause,' Sanghavi said. Sorting to allay the apprehensions, Pankaj Patel, chairman, Zydus Lifesciences , which also manufactures Covid DNA vaccine, said in a post on X, 'There are other multiple reasons like age, environmental factors, genetics, lifestyle etc, that could be the leading cause of heart attacks in people. Several scientific studies globally and in India have conclusively shown that the risk of heart attack or myocarditis is greater after SARS-CoV-2 infection. #Vaccines save lives.' Appreciating the vaccination programme, Patel said, "the massive vaccination programme in our country during the peak of Covid phase saved millions of people and families. In fact a study published in Lancet estimated that India averted almost 3.4 million deaths due to vaccination in the year 2021," he said. Live Events Satish Reddy, chairman, Dr Reddy's Laboratories, wrote, 'India-made vaccines are by WHO and used worldwide. They helped end polio and fight Covid. At a time when India is seen as a vaccine leader, let's build trust in science, not doubt it. Public health must stay above politics.' A post on X attributed to Samir Mehta, executive chairman, Torrent Pharma said, 'India has earned global recognition as the Pharmacy of the World, supplying safe and effective vaccines to over 90 countries…Let's not allow misinformation to erode trust in science or the integrity of India's healthcare ecosystem.' Responding to rising concerns over the sudden deaths of more than 20 people in Hassan district, the Karnataka health department formed an expert committee to probe a possible link to Covid vaccines. However, support came pouring in for Covid vaccines. The Indian Vaccine Manufacturers Association said Covid-19 vaccines were developed and manufactured in the country with the highest safety and quality standards. Assuring about the safety of these vaccines, Dr/ G.V.J.A. Harshavardhan, director general at the association said the approvals were based on extensive evaluation in preclinical studies and human clinical trials with positive results on safety, efficacy, and immunogenicity of the vaccines. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' he said in a statement. He said prior to releasing the vaccines, they were tested extensively for safety by the manufacturers and are also provided batch release certification by the Central Drugs Laboratory (CDL) of the Ministry of Health and Family Welfare. Sudarshan Jain, secretary general, Indian Pharmaceutical Alliance (IPA) said during the pandemic, vaccines played a crucial role, and India consistently supplied medicines and vaccines across the world. "These vaccines have been well documented and rigorously tested as per regulatory processes. Misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally".
Mint
an hour ago
- Mint
AIIMS says no link between covid jabs and sudden deaths among young adults
Doctors at Delhi's All India Institute of Medical Sciences (AIIMS-Delhi) have refuted claims linking Covid-19 vaccines to sudden deaths in young adults in the country. This comes in the backdrop of recent claims by Karnataka Chief Minister Siddaramaiah stating that covid vaccines were linked to sudden deaths due to cardiac arrest among young adults in the state's Hassan district. The country's premier medical institution announced that its studies have found no such connection, instead attributing these tragic incidents primarily to lifestyle factors such as smoking, high blood pressure, and stress. Senior AIIMS doctors emphasized the crucial role these vaccines played in saving lives during the pandemic, noting that the studies are ongoing to determine the causes of sudden unexplained deaths. Researchers at AIIMS's pathology department are currently undertaking genomic studies to find the unexplained causes of death in approximately 25% of cases involving young individuals, where no apparent cause was initially identified. The pharmaceutical industry has also vouched for vaccine safety and debunked doubts over efficacy. Dr. Abhishek Yadav, additional professor in the department of forensic medicine at AIIMS, detailed two studies conducted by his department. A retrospective analysis from 2018 to 2022, comparing pre- and post-Covid data, found "no surge in the sudden cardiac deaths in the cases which were reported in the department". A second, ongoing study, initiated in 2023 in collaboration with the Indian Council of Medical Research (ICMR) and slated to continue for another year and a half, aims to gather more samples for scientifically validated results. This study has so far examined approximately 230 death cases, collecting family history, performing genomic and DNA level studies, and utilizing virtual autopsies. Dr. Yadav stated that this second study has also 'not found any link between covid vaccine and sudden deaths.' The research categorized cases into two age groups: 18-45 years and 45-65 years. Dr. Yadav said that coronary artery disease was identified as the most common historical factor, with over 50% of these cases linked to lifestyle factors and substance abuse, such as alcohol and smoking. The pathology department of AIIMS is continuing genomic studies on the remaining 25% of unexplained cases. Dr. Sudheer Arava, a professor in the department of pathology at AIIMS, explained that the study of 230 young individuals brought to the forensic department found heart attack to be the most common cause of death (50%), often linked to lifestyle risk indicators like high blood pressure, cholesterol, stress, and obesity. 'In 25% of cases, no identifiable cause of death was determined, and researchers are exploring potential molecular alterations. An interim report submitted to the ICMR indicates that nearly 50% of the deaths studied were due to heart attacks, with further research ongoing.' Dr. Sanjay Rai, professor at the department of community medicine at AIIMS, stated that the Covishield vaccine (developed by Oxford–AstraZeneca) showed an efficacy of 62.1%. He highlighted that various regulatory authorities have approved 37 different Covid-19 vaccines, with the World Health Organization (WHO) approving approximately 12, utilizing diverse technologies. For instance, Bharat Biotech's Covaxin uses a traditional technology, while Covishield and Russian Sputnik V are based on an adenovirus vector. Globally, over 13 billion vaccine doses have been administered, with countries like the United States completing fourth doses. The WHO now recommends vaccination for everyone aged six months and above, particularly with vaccines effective against newer variants. Dr. Karan Madan, associate professor in the department of pulmonary medicine, affirmed that Covid-19 vaccines were "highly effective and instrumental in lowering mortality rates during the pandemic". He emphasized their role as the "sole possible measure to save lives" at the time, providing "immense advantages" in preventing excess deaths. Dr. Madan also referenced a study on sudden cardiac deaths that found "no clear association" with vaccine usage. Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA), underscored India's role as a knowledge-driven sector, accounting for 60% of global vaccine production. He stated that Covid vaccines were "well documented and rigorously tested as per regulatory processes," warning that "misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally". The Indian Vaccine Manufacturers Association also said that all Covid-19 vaccines in India received Emergency Use Authorization based on extensive preclinical and human clinical trial evaluations, showing positive results for safety, efficacy, and immunogenicity. Covid infections have been on a declining trend after showing a steady increase in the past few weeks. On Thursday, the country's active caseload dropped to 1,290 from 1,691 cases, with no deaths reported in the last 24 hours. The total number of Covid-19-related deaths this year stands at 146. The current spread is linked to Omicron sub-variants NB.1.8.1 and LF.7.
Time of India
3 hours ago
- Time of India
It's wrong to blame Covid jabs for cardiac arrests: Biocon chief Kiran Mazumdar-Shaw
Bengaluru: Days after chief minister Siddaramaiah blamed Covid-19 vaccines for the alarming rise in cardiac arrest cases among youngsters in the recent weeks, especially in Hassan district, Biocon chairperson Kiran Mazumdar-Shaw said Thursday his comments were "factually incorrect" and would contribute to "public misinformation". With close to 25 deaths due to cardiac arrests in Hassan alone in the last 40 days, Siddaramaiah said on Tuesday the "hasty approval and distribution of Covid vaccines" could also be a reason for the fatalities. Mazumdar-Shaw, however, wrote on X: "Covid-19 vaccines developed in India were approved under the emergency use authorisation framework, following rigorous protocols aligned with the global standards for safety and efficacy." You Can Also Check: Bengaluru AQI | Weather in Bengaluru | Bank Holidays in Bengaluru | Public Holidays in Bengaluru Responding to the CM's comment, she said, "To suggest that these vaccines were hastily approved is factually incorrect and contributes to public misinformation." Mazumdar-Shaw added, "These vaccines have saved millions of lives and, like all vaccines, may cause side effects in a very small number of individuals. It is important to acknowledge the science and data-driven processes behind their development, rather than engage in retrospective blame." As the cardiac arrest-linked casualties in Hassan district snowballed into a major controversy, the CM commented, "The state govt has taken the matter seriously and an expert committee has been constituted under the chairmanship of Dr Ravindranath, director of Jayadeva Institute of Cardiovascular Sciences and Research, to ascertain the exact cause of these deaths and to find solutions. The committee has been instructed to submit a report within 10 days. " The same committee in Feb 2025 was also tasked with conducting a thorough study on reasons behind sudden deaths of youngsters in Karnataka and exploring whether these fatalities were triggered by the Covid vaccines. Mazumdar-Shaw commented, "Heart attacks being linked to Covid vaccines even after four years does not stack up. There are many other reasons, including performance-enhancing drugs, excessive exercise routines, etc. "
